« Back
Home /
Infliximab

Infliximab

Manufacturer	MedChem Express
Category	Antibodies Primary Antibodies
Type	Antibody Monoclonal
Specific against	other
Amount	1 mg
Item no.	HY-P9970-1mg
Targets	TNF
CASRN	170277-31-3
eClass 6.1	32160702
eClass 9.0	42030590
Available
Product Description	Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research[1][2].
StorageTemperature	Store at -80°C for 2 years
Shipping	Dry Ice
Manufacturers Applications	Metabolism-sugar/lipid metabolism
MolecularWeight	N/A
Clinical_Information	Launched
Manufacturers Research_Area	Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cancer
Solubility	H2O : 100 mg/mL (ultrasonic)
Isoform	TNFRSF5/CD40
Pathway	Anti-infection; Apoptosis
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Request delivery time